Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M. C. van Maaren"'
Autor:
A. Klaassen-Dekker, C. H. C. Drossaert, M. C. Van Maaren, A. E. Van Leeuwen-Stok, V. P. Retel, J. C. Korevaar, S. Siesling, on behalf of the NABOR project group
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Follow-up of curatively treated primary breast cancer patients consists of surveillance and aftercare and is currently mostly the same for all patients. A more personalized approach, based on patients’ individual risk of recurre
Externí odkaz:
https://doaj.org/article/49058356ce79496fa87979bbb504f267
Autor:
D. J. P. van Uden, M. C. van Maaren, L. J. A. Strobbe, P. Bult, J. J. van der Hoeven, S. Siesling, J. H. W. de Wilt, C. F. J. M. Blanken-Peeters
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-9 (2019)
Abstract Background Distant metastatic disease is frequently observed in inflammatory breast cancer (IBC), with a poor prognosis as a consequence. The aim of this study was to analyze the association of hormone receptor (HR) and human epidermal growt
Externí odkaz:
https://doaj.org/article/0ae8442a54bf47a7b20c2fcba257c4df
Autor:
M. A. A. Ragusi, B. H. M. van der Velden, M. C. van Maaren, E. van der Wall, C. H. van Gils, R. M. Pijnappel, K. G. A. Gilhuijs, S. G. Elias
Publikováno v:
Breast Cancer Research and Treatment, 193(1), 161-173
Breast Cancer Research and Treatment 193 (2022) 1
Breast cancer research and treatment, 193(1), 161-173. Springer
Breast Cancer Research and Treatment 193 (2022) 1
Breast cancer research and treatment, 193(1), 161-173. Springer
Purpose Although adjuvant systemic therapy (AST) helps increase breast cancer-specific survival (BCSS), there is a growing concern for overtreatment. By estimating the expected BCSS of AST using PREDICT, this study aims to quantify the number of pati